CS
Cheng Sohanya Roshan
Other
100.660 €
▼ Ventas (8 oper.)
Historial del iniciado
OtroTodavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Explore the full record of transactions filed by Cheng Sohanya Roshan. Officer active across 1 company, notably Karyopharm Therapeutics Inc.. In total, 19 reports have been published. Breakdown: 0 buy · 8 sells. Total volume traded: €101k. Activity tracked since 30 June 2021. The latest transaction was disclosed on 14 May 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Cheng Sohanya Roshan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones19 en total
324 títulos@ 9,50 US$0.0015% mcap16.4% de su flujoCommon StockSEC:0001193125-26-226652:1
947 títulos0Common StockSEC:0001193125-26-226652:0
4604 títulos@ 9,4095 US$36.6% de su flujoCommon StockSEC:0001865796-26-000003:0
32.415 títulos0Common StockSEC:0001193125-26-035687:0
43.650 títulos0Common StockSEC:0001193125-25-241468:0
945 títulos0Common StockSEC:0001193125-25-205042:0
3445 títulos@ 6,29 US$32.4% de su flujoCommon StockSEC:0000950170-25-034743:0
5416 títulos0Common StockSEC:0000950170-25-032323:0
5356 títulos@ 0,7218 US$5.5% de su flujoCommon StockSEC:0000950170-24-103998:0
21.840 títulos@ 1,17 US$36.9% de su flujoCommonSEC:0000950170-24-025189:0
198.959 títulos0Common StockSEC:0000950170-24-023285:0
14.167 títulos0Common StockSEC:0000950170-24-007621:0
7415 títulos@ 1,3313 US$14.3% de su flujoCommon StockSEC:0001209191-23-048159:0
1839 títulos@ 2,35 US$6.3% de su flujoCommon StockSEC:0001209191-23-036248:0
100.000 títulos0Common StockSEC:0001209191-23-014861:0
30.000 títulos0Common StockSEC:0001209191-22-048395:0
66 títulos@ 5,345 US$0.0002% mcap100.0% de su flujoCommon StockSEC:0001209191-22-036812:0
84.000 títulos0Common StockSEC:0001209191-22-014622:0
7500 títulos0Common StockSEC:0001209191-21-044423:0
About Cheng Sohanya Roshan
Cheng Sohanya Roshan is a declarant associated with Karyopharm Therapeutics Inc. in the role of EVP & Chief Commercial Officer. The record shows 19 filings in total, and across the recent filings tracked, the transactions are sales for EUR 100660, with a date range from 2021-07-01 to 2026-05-15; the most frequent transaction nature is Attribution.